CEREBROLYSIN 60 MG

Cerebrolysin is a neurotrophic peptide blend for serious brain research—stroke, TBI, cognitive decline, and neurodegeneration. It’s used internationally and has a long history in the literature for supporting brain repair and plasticity.

How It Works
Cerebrolysin contains low–molecular weight peptides and amino acids that mimic endogenous neurotrophic factors like BDNF and NGF. It activates PI3K/Akt and MAPK/ERK pathways, promoting neuronal survival, neurogenesis, and synaptic plasticity. It also shows anti-excitotoxic and anti-apoptotic effects in neuronal injury models.

Regulatory & Research Note
Cerebrolysin is approved for certain neurological indications in some countries, but it is not FDA-approved in the United States. This product is provided for research use only and is not for human therapy.